NASDAQ:CHNG
Change Healthcare
- Stock
Last Close
27.42
30/09 20:00
Volume Today
28.98M
Avg: -
PE Ratio
−146.46
PFCF: -
Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | ||
|---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 34.08M - | 62.81M 84.27% | 80.86M 28.74% | |||
average receivables | 9.14M - | 437.72M 4,688.25% | 869.38M 98.62% | 874.21M 0.56% | ||
book value per share | 8.59 - | 8.27 3.75% | 23.98 190.11% | 23.74 1.01% | 10.11 57.41% | |
capex per share | -0.09 - | -1.80 1,794.95% | -0.85 52.59% | |||
capex to depreciation | -0.42 - | -0.42 1.35% | -0.40 3.07% | |||
capex to operating cash flow | 0.08 - | -0.42 597.59% | -0.40 5.68% | |||
capex to revenue | -0.07 - | -0.08 20.67% | -0.08 0.44% | |||
cash per share | 0.02 - | 3.00 11,938.87% | 0.83 72.44% | 0.78 5.68% | ||
days of inventory on hand | ||||||
days payables outstanding | 348.31 - | 13.69 96.07% | 23.28 70.04% | |||
days sales outstanding | 1.62K - | 102.22 93.69% | 92.59 9.42% | |||
debt to assets | 0.49 - | 0.47 3.99% | 0.47 0.92% | |||
debt to equity | 1.52 - | 1.47 2.95% | 1.42 3.39% | |||
dividend yield | ||||||
earnings yield | 0.01 - | -0.01 185.33% | -0.17 2,417.79% | -0.01 93.56% | -0.00 77.10% | |
enterprise value | 7.71B - | 7.70B 0.04% | 10.16B 31.82% | 14.93B 47.02% | 27.31B 82.88% | |
enterprise value over ebitda | -131.38 - | -109.11 16.95% | -9.73 91.08% | 21.63 322.24% | 33.56 55.15% | |
ev to operating cash flow | 2.26K - | -65.98 102.92% | 25.47 138.61% | 39.18 53.83% | ||
ev to sales | 51.61 - | 4.83 90.64% | 7.84 62.37% | |||
free cash flow per share | 0.02 - | -1.22 4,998.18% | 2.48 303.57% | 1.30 47.66% | ||
free cash flow yield | 0.00 - | -0.03 6,869.14% | 0.03 210.75% | 0.02 44.58% | ||
graham net net | -1.35 - | -1.18 12.96% | -42.02 3,468.60% | -44.51 5.93% | -17.72 60.19% | |
graham number | 9.27 - | 8.40 9.37% | 61.09 627.01% | 20.92 65.76% | 6.35 69.65% | |
income quality | -0.07 - | 0.16 347.91% | -5.22 3,316.01% | -12.14 132.44% | ||
intangibles to total assets | 0 - | 0 | 0.81 Infinity% | 0.82 1.60% | 0.82 0.36% | |
interest coverage | -42.71 - | 0.41 100.96% | 0.55 34.17% | |||
interest debt per share | 36.54 - | 36.77 0.64% | 15.12 58.89% | |||
inventory turnover | ||||||
invested capital | 1.52 - | 1.47 2.95% | 1.42 3.39% | |||
market cap | 7.71B - | 7.71B 0% | 5.58B 27.64% | 10.25B 83.81% | 22.89B 123.32% | |
net current asset value | -181.30M - | -160.77M 11.32% | -5.42B 3,271.68% | -5.74B 5.92% | -5.34B 6.93% | |
net debt to ebitda | 0.05 - | -4.39 9,189.19% | 6.78 254.50% | 5.42 20.02% | ||
net income per share | 0.44 - | -0.38 185.33% | -6.92 1,721.88% | -0.82 88.16% | -0.18 78.37% | |
operating cash flow per share | 0.02 - | -1.12 4,616.67% | 4.28 480.82% | 2.15 49.73% | ||
payables turnover | 1.05 - | 26.66 2,444.14% | 15.68 41.19% | |||
receivables turnover | 0.23 - | 3.57 1,484.57% | 3.94 10.40% | |||
research and ddevelopement to revenue | 0.06 - | 0.07 25.07% | 0.08 8.69% | |||
return on tangible assets | 0.04 - | -0.04 190.27% | -0.49 1,115.83% | -0.06 87.31% | -0.03 47.07% | |
revenue per share | 1.44 - | 22.56 1,470.40% | 10.74 52.38% | |||
roe | 0.05 - | -0.05 188.65% | -0.29 528.00% | -0.03 88.04% | -0.02 49.23% | |
roic | 0.00 - | -0.00 574.27% | -0.07 9,803.56% | 0.01 112.52% | 0.01 7.30% | |
sales general and administrative to revenue | 0.20 - | |||||
shareholders equity per share | 8.59 - | 8.27 3.75% | 23.98 190.11% | 23.74 1.01% | 10.11 57.41% | |
stock based compensation to revenue | 0.01 - | 0.02 120.93% | 0.03 44.02% | |||
tangible asset value | 1.18B - | 1.13B 3.75% | -4.88B 530.53% | -5.04B 3.44% | -4.90B 2.83% | |
tangible book value per share | 8.59 - | 8.27 3.75% | -35.59 530.53% | -36.82 3.44% | -15.13 58.91% | |
working capital | -780K - | 341.39M 43,868.21% | 71.71M 79.00% | 233.24M 225.26% |
All numbers in USD (except ratios and percentages)